Karuna Therapeutics Inc.

NASDAQ: KRTX · Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM

Karuna Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
654K 10.64M 36.96M
Cost of Revenue
1.7M 1.11M 506K
Gross Profit
-1.05M 9.53M 36.46M
Operating Income
-494.78M -289.68M -143.85M
Interest Income
61.18M 14.18M 502K
Pretax Income
-433.01M -274.92M -143.8M
Net Income
-433.68M -276.34M -143.81M
Selling & General & Admin
131.33M 76.07M 52.62M
Research & Development
364.1M 224.25M 128.2M
Other Expenses
588K 580K 254K
Operating Expenses
495.43M 300.31M 180.82M
Interest Expense
n/a 14.18M n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
495.43M 300.31M 180.82M
Income Tax Expense
670K 1.42M 6K
Shares Outstanding (Basic)
36.96M 31.63M 29.14M
Shares Outstanding (Diluted)
36.96M 31.63M 29.14M
EPS (Basic)
-11.73 -8.74 -4.94
EPS (Diluted)
-11.73 -8.74 -4.94
EBITDA
-493.08M -289.68M -143.15M
EBIT
-494.78M -260.74M -143.85M
Depreciation & Amortization
1.7M 1.11M 702K